RE:Health Canada ApprovalAwareness will definitely grow if Health Canada does not object to a phase 2 trial. What was highlighted to me from the last news release was the Trial will test inflammation in the Lung and Kidney. As a long term shareholder, to me this is derisking the trial and makes me a lot more bullish. Now Arch could have 2 pathways to potential billion dollar markets with one trial! With Covid 19, the technology has potential to substantially reduce hospitalization and without Covid 19 we could see $22 a share annually. This isn't a recycled drug, this isn't an idea, this is a Patented Drug Library with no competition.
As for Halting, I have been in this play for 3 years and I have only see it halt once. Through FDA applications for phase 1, approvals etc. I would rather a End day or Before Market press release to and let the market do its thing.
Awareness is what I have found to be the underlying reason for lower volume this week and National Media could cover this story which would change the game forever.
Good luck to all longs
I am invested in the science